Alan P Lindsay - Net Worth and Insider Trading

Alan P Lindsay Net Worth

The estimated net worth of Alan P Lindsay is at least $126 dollars as of 2024-11-08. Alan P Lindsay is the 10% Owner of Q BioMed Inc and owns about 1,262,245 shares of Q BioMed Inc (QBIO) stock worth over $126. Details can be seen in Alan P Lindsay's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan P Lindsay has not made any transactions after 2017-04-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Alan P Lindsay

Alan P Lindsay Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alan P Lindsay owns 4 companies in total, including Q BioMed Inc (QBIO) , Uranium Energy Corp (UEC) , and Hydrocarb Energy Corp (HECCQ) among others .

Click here to see the complete history of Alan P Lindsay’s form 4 insider trades.

Insider Ownership Summary of Alan P Lindsay

Ticker	Comapny	Transaction Date	Type of Owner
QBIO	Q BioMed Inc	2017-04-11	10 percent owner
UEC	Uranium Energy Corp	2005-12-05	director
HECCQ	Hydrocarb Energy Corp	2010-02-10	director
		2007-06-08	director

Alan P Lindsay Latest Holdings Summary

Alan P Lindsay currently owns a total of 1 stock. Alan P Lindsay owns 1,262,245 shares of Q BioMed Inc (QBIO) as of April 11, 2017, with a value of $126.

Latest Holdings of Alan P Lindsay

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
QBIO	Q BioMed Inc	2017-04-11	1,262,245	0.00	126

Holding Weightings of Alan P Lindsay

Alan P Lindsay Form 4 Trading Tracker

According to the SEC Form 4 filings, Alan P Lindsay has made a total of 0 transactions in Q BioMed Inc (QBIO) over the past 5 years. The most-recent trade in Q BioMed Inc is the sale of 11,900 shares on April 11, 2017, which brought Alan P Lindsay around $72,709.

Insider Trading History of Alan P Lindsay

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alan P Lindsay Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alan P Lindsay Ownership Network

Ownership Network List of Alan P Lindsay

No Data

Ownership Network Relation of Alan P Lindsay

Alan P Lindsay Owned Company Details

What does Q BioMed Inc do?

Who are the key executives at Q BioMed Inc?

Alan P Lindsay is the 10 percent owner of Q BioMed Inc. Other key executives at Q BioMed Inc include director & 10 percent owner & Chief Legal Officer William S Rosenstadt , and director & 10 percent owner & Chief Executive Officer Denis Corin .

Q BioMed Inc (QBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Q BioMed Inc (QBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Q BioMed Inc (QBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Q BioMed Inc (QBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Q BioMed Inc Insider Transactions

No Available Data

What does Uranium Energy Corp do?

Who are the key executives at Uranium Energy Corp?

Alan P Lindsay is the director of Uranium Energy Corp. Other key executives at Uranium Energy Corp include Executive Vice President Scott Melbye , director & President and CEO Amir Adnani , and Interim Chief Financial Office Pat Obara .

Uranium Energy Corp (UEC) Insider Trades Summary

Over the past 18 months, Alan P Lindsay made no insider transaction in Uranium Energy Corp (UEC). Other recent insider transactions involving Uranium Energy Corp (UEC) include a net sale of 149,000 shares made by Volpe Vincent Della , a net sale of 33,000 shares made by David Kong , and a net purchase of 60,000 shares made by Amir Adnani .

In summary, during the past 3 months, insiders sold 0 shares of Uranium Energy Corp (UEC) in total and bought 69,500 shares, with a net purchase of 69,500 shares. During the past 18 months, 274,632 shares of Uranium Energy Corp (UEC) were sold and 69,500 shares were bought by its insiders, resulting in a net sale of 205,132 shares.

Uranium Energy Corp (UEC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Uranium Energy Corp Insider Transactions

No Available Data

What does Hydrocarb Energy Corp do?

Who are the key executives at Hydrocarb Energy Corp?

Alan P Lindsay is the director of Hydrocarb Energy Corp. Other key executives at Hydrocarb Energy Corp include CFO Kwongyip Andrew Lai , Secretary & Treasuer & CFO Johnathan Lindsay , and director & Chairman Randall Reneau .

Hydrocarb Energy Corp (HECCQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Hydrocarb Energy Corp (HECCQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hydrocarb Energy Corp (HECCQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Hydrocarb Energy Corp (HECCQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Hydrocarb Energy Corp Insider Transactions

No Available Data

What does Marker Therapeutics Inc do?

Who are the key executives at Marker Therapeutics Inc?

Alan P Lindsay is the director of Marker Therapeutics Inc. Other key executives at Marker Therapeutics Inc include Interim CFO Eliot M Lurier , 10 percent owner Mohamad Makhzoumi , and 10 percent owner Carmen Chang .

Marker Therapeutics Inc (MRKR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marker Therapeutics Inc Insider Transactions

No Available Data

Alan P Lindsay Mailing Address

Above is the net worth, insider trading, and ownership report for Alan P Lindsay. You might contact Alan P Lindsay via mailing address: 580 Hornby Street, Fifth Floor, Vancouver Bc Canada V6c 2e7 A1.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.